Akanda Corp

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which provides premium quality and ethically sourced medical cannabis products to patients worldwide. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers in international markets. It also imports and sells medical cannabis-based products to the domestic market in the United Kingdom. The company was founded on July 16, 2021 and is headquartered New Romney, the United Kingdom.

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom.

London, United Kingdom--(Newsfile Corp. - March 27, 2024) - On March 24, 2024, Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, entered into an underwriting agreement (the "Underwriting Agreement") with Univest Securities, LLC ("Univest") as the underwriter in connection with the issuance and sale by the Company in an underwritten public offering (the "Offering") of 3,087,443 of the Company's Common Shares, no par value per share (the "Common Shares" and, such number of Common Shares issued and sold in the Offering, the "Offered Shares"), at a purchase price of $0.1217 per Offered Share, and pre-funded warrants to purchase 37,997,190 Common Shares at a purchase price of each pre-funded warrant equal to the price at which one Common Share is sold in the Offering, minus $0.0001, and the exercise price of each pre-funded warrant is $0.0001 per share (the "Pre-Funded Warrants" and, such number of Pre-Funded Warrants issued and sold in the Offering, the "Offered Pre-Funded Warrants"), pursuant to the Company's effective registration statement on Form F-1 (File No. 333-277182) and a related preliminary prospectus, together with the related final prospectus dated as of March 26, 2024 (such registration statement, preliminary prospectus and the final prospectus, collectively, the "Registration Statement"), filed with the Securities and Exchange Commission.

Akanda Corp. Announces Closing of Underwritten Public Offering

London, United Kingdom--(Newsfile Corp. - March 25, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has entered into a firm commitment underwriting agreement with Univest Securities, LLC, as underwriter, whereby Univest has agreed to purchase up to 41,084,634 common shares or pre-funded warrants at a public offering price of $0.1217 per share or $0.1216 per pre-funded warrant in an underwritten public offering. The gross proceeds to Akanda are estimated to be approximately $5,000,000 before deducting the underwriter fees and other offering expenses.

Akanda Corp. Announces Pricing of Underwritten Public Offering

London, United Kingdom--(Newsfile Corp. - March 1, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced the signing of a definitive Share Purchase Agreement and Escrow Agreement with Somai Pharmaceuticals Unipessoal, LDA ("Somai"), marking a significant milestone in the sale of its Portuguese subsidiary, RPK BioPharma Unipessoal, LDA ("RPK"). This strategic move underscores both companies' commitment to advancing the medical cannabis industry and enhancing patient access to high-quality cannabis treatments.

RETRANSMISSION: Akanda Corp. Signs Share Purchase and Escrow Agreements for the Sale of Portuguese Assets to Somai Pharmaceuticals

London, United Kingdom--(Newsfile Corp. - February 29, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced the signing of a definitive Share Purchase Agreement and Escrow Agreement with Somai Pharmaceuticals Unipessoal, LDA ("Somai"), marking a significant milestone in the sale of its Portuguese subsidiary, RPK BioPharma Unipessoal, LDA ("RPK"). This strategic move underscores both companies' commitment to advancing the medical cannabis industry and enhancing patient access to high-quality cannabis treatments.

Akanda Corp. Signs Share Purchase and Escrow Agreements for the Sale of Portuguese Assets to Somai Pharmaceuticals

London, United Kingdom--(Newsfile Corp. - February 20, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announces that it has received an order from the Ontario Superior Court of Justice (the "Court") permitting Akanda to hold its annual meeting of shareholders (the "Meeting") on or before March 23, 2024, pursuant to an application to the Court previously announced by the Company on February 20, 2024. Prior to the order from the Court, the Company would have had to hold the Meeting on or before February 22, 2024.

Akanda Corp. Provides Further Update on Annual Meeting of its Shareholders

London, United Kingdom--(Newsfile Corp. - February 20, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announces that it has made an application to the Ontario Superior Court of Justice (the "Court") to extend the deadline for it to hold its annual meeting of shareholders (the "Meeting") from February 22, 2024 to March 23, 2024. Under Ontario law, the Company must hold the Meeting within 15 months from the prior meeting, which would be February 22, 2024.

Akanda Corp. Provides Update on Annual Meeting of its Shareholders

London, United Kingdom--(Newsfile Corp. - February 13, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), provides an overview of the growing cannabis market in the United Kingdom and promising trends among patients. 2023 was a dynamic year for the UK cannabis market.

Akanda Corp. Discusses Positive Trends in UK Cannabis Market

London, United Kingdom--(Newsfile Corp. - February 2, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has closed its previously announced registered direct offering for the sale and issuance of 280,851 common shares at a purchase price of $0.406 per share, and pre-funded warrants to purchase 1,462,991 common shares at a price of $0.4059 per share, priced at-the-market under the Nasdaq rules. The pre-funded warrants are immediately exercisable for $0.0001 per share and may be exercised at any time until all of the pre-funded warrants are exercised in full, subject to certain beneficial ownership limitations as set forth in the pre-funded warrant.

Akanda Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

London, United Kingdom--(Newsfile Corp. - February 2, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announces it is actively following the developments in federal US policy to reschedule and/or deschedule cannabis under the Controlled Substances Act ("CSA"). The Company believes rescheduling may reinvigorate capital markets and could lead to changes in NASDAQ and NYSE rules on listing plant-touching U.S. companies.

Akanda Corp. Provides Update on Scheduling Policy in US Aims to Be Among First International Movers in US Pending Approval

London, United Kingdom--(Newsfile Corp. - February 1, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announces it has entered into an Amended Non-Binding Letter of Intent ("LOI")with Somai Pharmaceuticals Ltd. for the sale of RPK, its Portuguese subsidiary.

Akanda Corp. Entered into Non-Binding Letter of Intent for Sale of RPK

London, United Kingdom--(Newsfile Corp. - January 4, 2024) - International medical cannabis platform company Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") an Ontario company, announced today it received an extension of 180 calendar days from The Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the "Bid Price Requirement"), following the expiration of the initial 180 calendar days period to regain compliance on January 2, 2024. The Nasdaq determination is based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on The Nasdaq Capital Market with the exception of the Bid Price Requirement, and the Company's written notice of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary.

Akanda Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

London, United Kingdom--(Newsfile Corp. - December 11, 2023) - International medical cannabis platform company Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") an Ontario company, reported that it has appointed a new Chief Financial Officer. Effective immediately Charn Deol will join the Company and come to Akanda with more than 35 years of financial markets.

Akanda Corporation Announces CFO Appointment

Toronto, Ontario--(Newsfile Corp. - August 15, 2023) - Halo Collective Inc. (NEO: HALO) (OTC Pink: HCANF) (FSE: A9K0) ("Halo" or the "Corporation") has reported its financial results for the second quarter of 2023. Despite navigating a challenging market landscape, the company remains steadfast in its commitment to delivering quality products and adapting to changing industry dynamics.

Halo Collective Reports Q2 2023 Financial Results and Announces Delisting

Toronto, Ontario--(Newsfile Corp. - August 9, 2023) - Halo Collective Inc. (NEO: HALO) (OTC Pink: HCANF) (FSE: A9K0) ("Halo" or the "Corporation"), a leading player in the cannabis industry, has released its financial results for the fourth quarter of 2022 and first quarter of 2023. Fourth Quarter 2022 Financial Highlights: During the three months ended December 31, 2022, the Company reported revenues of $4,565,601, down from $8,365,976 in the three months ended December 31, 2021.

Halo Collective Provides Fourth Quarter 2022, First Quarter 2023 Financial Results

LONDON--(BUSINESS WIRE)--International medical cannabis platform company Akanda Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN) today announced that the Company has received a written notification (the “Notification Letter”) on July 3, 2023 from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2). It resulted from the fact that th.

Akanda Corp. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Toronto, Ontario--(Newsfile Corp. - June 22, 2023) - Halo Collective Inc. (NEO: HALO) (OTCQB: HCANF) (FSE: A9K0) ("Halo" or the "Company") announces today that it has changed its auditor (the "Change of Auditor") from Macias Gini & O'Connell LLP (the "Former Auditor") to GreenGrowth CPAs (the "Successor Auditor"). The Former Auditor resigned effective June 19, 2023, and the Company's board of directors, upon the audit committee's recommendation, appointed the Successor Auditor to fill the resulting vacancy until the close of the next annual meeting of the Company's shareholders.

Halo Collective Announces Change of Auditors and Failure to File Cease Trade Order

FRANKFURT, Germany & LONDON--(BUSINESS WIRE)--International Medical Cannabis Company, Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN, WKN: A3DG83) announces that Akanda and Veridia Canada Ltd. (the “Lender”) have mutually agreed to terminate the loan agreement between the parties previously announced on April 18, 2023 (the “Loan Agreement”). Akanda has returned all funds provided under the terms of the Loan Agreement and has no further obligations owing to the Lender pursuant to the Loa.

Akanda Corp. Announces Termination of Loan Agreement

Toronto, Ontario--(Newsfile Corp. - May 26, 2023) - Halo Collective Inc. (NEO: HALO) (OTCQB: HCANF) (FSE: A9K0) ("Halo" or the "Corporation") is providing an update to its previously announced management cease trade order (the "MCTO") granted by the Ontario Securities Commission (the "OSC") under National Policy 12-203 - Management Cease Trade Orders ("NP 12-203"). Pursuant to the MCTO, the Corporation's CEO, Katie Field, and the Corporation's CFO, Marshall Minor, may not trade in securities of the Corporation until such time as the Corporation files its annual audited financial statements, annual management's discussion and analysis and related certifications for the year ended December 31, 2022 (collectively, the "Required Documents"), and the OSC revokes the MCTO.

Halo Collective Provides Update on Status of Financial Statements

Ideanomics Inc

Sentage Holdings

Use these technical indicators when trading penny stocks The post The Penny Stock Trader's Guide to Technical Indicators appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

The Penny Stock Trader's Guide to Technical Indicators

Akanda (NASDAQ: AKAN ) stock is on the rise Wednesday after the cannabis company released its annual report. Akanda originally filed a notice with the Securities and Exchange Commission (SEC) yesterday noting that it would be late in filing its annual report.

Why Is Akanda (AKAN) Stock Up 114% Today?

Toronto, Ontario--(Newsfile Corp. - May 1, 2023) - Halo Collective Inc. (NEO: HALO) (OTCQB: HCANF) (FSE: A9K0) ("Halo" or the "Company") is providing disclosure regarding recent share issuances to Reef Capital Inc. ("Reef") in connection with a convertible promissory note among Reef and the Company for a principal amount of up to $5,000,000, as disclosed in Company's news release dated November 9, 2023 (the "Convertible Loan Facility"). To date, the Company has drawn approximately $3.95 million on the Convertible Loan Facility, and upon notices of conversion issued by Reef to the Company between November, 2022 and February, 2023 (the "Reef Notices"), approximately 123,161,500 common shares of the Company were issued in full satisfaction of the outstanding loan amount of $3.95 million (the "Reef Share Issuances").

Halo Collective Provides Disclosure on Share Issuances Pursuant to Convertible Loan Facility

FRANKFURT, Germany & LONDON--(BUSINESS WIRE)--International medical cannabis company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN, WKN: A3DG83) announces that it has entered into a loan agreement dated April 26, 2023 (the “Loan Agreement”) with Veridia Canada Ltd. (the “Lender”), in the principal amount of €500,000 (approximately C$738,650) (the “Loan”), which has been advanced in full by the Lender. The Loan is expected to be used for the short-term financial commitments of Akanda an.

Akanda Corp. Announces Loan Agreement

LONDON--(BUSINESS WIRE)--International medical cannabis platform company Akanda Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN) an Ontario company, today announced that it received a notification letter (the “Notification Letter on Compliance”) from the Listing Qualifications Department of The Nasdaq Stock Market Inc.

Akanda Corporation Has Regained Compliance with NASDAQ's Minimum Bid Price Requirement

Toronto, Ontario--(Newsfile Corp. - March 20, 2023) - Halo Collective Inc. (NEO: HALO) (OTCQB: HCANF) (FSE: A9K0) ("Halo" or the "Corporation") announced today that it does not anticipate being in a position to file its audited annual financial statements (the "Issuer Statements"), management's discussion and analysis and related certifications for the financial year ended December 31, 2022 on or before March 31, 2023, as required, due to a recent change of auditor for the Corporation and the additional steps required for third party valuations needed for audit purposes. Accordingly, the Corporation has requested the issuance of a management cease trade order under the provisions of National Policy 12-203 Management Cease Trade Orders ("NP 12-203") so as to permit the continued trading in the Corporation's common shares by persons other than insiders and employees of the Corporation.

Halo Collective Announces Delay in Filing Audited Annual Financial Statements

LONDON--(BUSINESS WIRE)--International medical cannabis platform company Akanda Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN) an Ontario company, reported that it expects to implement a 1-for-10 reverse stock split on its ordinary shares effective Thursday March 9, with trading to begin on a split-adjusted basis at the market open on that day. Trading in the ordinary shares will continue on the Nasdaq Capital Market under the symbol “AKAN”.

News for Akanda Corp Stock (AKAN)